In 2017, the FDA approved Genentech’s Ocrevus (ocrelizumab) for the treatment of relapsing forms of multiple sclerosis (MS) and primary progressive MS (PPMS) in adults. It was the first and remains the only disease-modifying treatment (DMT) FDA-approved for treating PPMS. The antibody is now approved in more than 100 countries, and over 300,000 people with […]
Category Archives: Congenital disorders
© Maksym Yemelyanov stock.adobe.com #image-caption p{ font-size: 12px; max-width: 525px; margin: 0 auto; text-align: center; } The average annual premium for employer-sponsored single and family coverage increased by 7% in 2023, an increase from 2022, but roughly in line with the rate of inflation (5.8%) and wage growth (5.2%), according to the annual KFF Employer […]
The educational content in this post, elaborated in collaboration with Bromatech, was independently developed and approved by the GMFH publishing team and editorial board. Getting diagnosed with IBS The use of symptom-based criteria for the diagnosis of gastrointestinal functional disorders may help physicians to diagnose and legitimize such disorders, and not be seen only as […]
Every Oct. 18, we celebrate a global community of patients, family, researchers and healthcare providers devoted to raising awareness of lamin A-related congenital muscular dystrophy. Their common goal is to educate the public about this disease and to advocate to lawmakers, philanthropists, and biotech and pharmaceutical companies for better diagnostic and treatment options. What is […]
Introduction Onychotillomania is a condition in which patients have a compulsive or irresistible urge to pick or pull at their nail unit constantly. This term derives from the Greek words onycho (nail), tillo (to pull), and mania (madness). The habit of nail picking typically develops at around 10.2 years of age, with a range of […]
Aline Saliba loves understanding the science behind paediatric medicine.Credit: Pablo Albarenga for Nature One of the Sustainable Development Goals set by the United Nations is to ensure healthy lives and promote well-being for all people, in part by lowering global maternal mortality and ending preventable deaths of newborn babies and children under five years old. […]
In this study, 32 final-year medical students in the internship phase were invited to participate in the interviews, of whom 15 individuals (47%) participated in the interviews. Among the participants, 13 individuals were aged between 24 and 29 years, and 2 individuals were aged between 30 and 35 years, with a mean age of 28.8 […]
Maternal mortality reduction was one of the many targets of the past Millennium Development Goals (MDG) target, during which many countries made notable gains. Despite gains, maternal mortality remains a serious matter beyond MDG global initiatives, especially in low- and middle-income countries.1–3 In observance of this, the Sustainable Development Goals (SDG)—2015–2030 considered it one priority […]